Brii Biosciences Limited 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Brii Biosciences Limited | 927,201 3.100% | -121,278 (-11.57%) | Filing |
| 2023-02-13 4:45 pm Purchase | 2022-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Brii Biosciences Limited | 1,048,479 5.400% | 1,048,479 (New Position) | Filing |